Endo Pharmaceuticals (ENDP) Reports Mixed Q1 Results
Tweet Send to a Friend
Endo Pharmaceuticals (Nasdaq: ENDP) reports Q1 EPS of $0.67 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
